Dashboard
Curated content
All companies
Job board
Funding rounds
Exits
Matching tool
Investment heatmap
Companies
InvaGen Pharmaceuticals
Save
InvaGen Pharmaceuticals
Fast growing generic pharmaceutical company.
Launch date
2003
Employees
51-200 people
Market cap
-
Enterprise valuation
€455m
(Public information from Sep 2015)
Town of Smithtown New York (HQ)
http://invagen.com
https://www.linkedin.com/company/cipla-usa/
B2B
manufacturing
health
marketing
crm & sales
biotechnology
biotech and pharma
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
InvaGen Pharmaceuticals funding
InvaGen Pharmaceuticals investors
Edit
Date
Investors
Amount
Round
Sep 2015
Cipla
$500m
Valuation: $500m
Acquisition
Total Funding
-
Recent News about InvaGen Pharmaceuticals
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access